Mesalamine 375 mg/1 (Mesalamine CAPSULE, EXTENDED RELEASE) 375 mg/1

Mesalamine 375 mg extended-release capsules are designed to deliver anti-inflammatory effects for gastrointestinal conditions. This medication is commonly used to manage symptoms associated with ulcerative colitis and other inflammatory bowel diseases.

Strength

375 mg/1

Pack Size

120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-9224-89)

Manufacturer / TM Owner

Teva Pharmaceuticals USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mesalamine is primarily used for the treatment of inflammatory bowel diseases, such as ulcerative colitis. It works by reducing inflammation in the colon and rectum. Mesalamine 375 mg extended-release capsules are designed to release the medication gradually, providing sustained relief. This medication is often prescribed to maintain remission and manage symptoms associated with these conditions.

Side Effects

Mesalamine may cause common side effects such as nausea, vomiting, and stomach pain. Some users may experience headaches, diarrhea, or mild skin rashes. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

Mesalamine should be handled with care, especially for individuals with known allergies to salicylates or other ingredients in the formulation. It is important to follow the prescribed dosage and administration instructions. Patients should inform their healthcare provider about any pre-existing conditions or other medications they are taking.

Avoid Interactions

Mesalamine may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other gastrointestinal treatments. Alcohol consumption should be moderated, as it may exacerbate side effects. Always consult a healthcare provider before combining mesalamine with other medications.

Frequently Asked Questions

Mesalamine is used to treat inflammatory bowel diseases, such as ulcerative colitis, by reducing inflammation in the colon and rectum.

Mesalamine works by delivering anti-inflammatory effects directly to the colon, helping to manage symptoms and maintain remission in inflammatory bowel diseases.

Common side effects of mesalamine include nausea, vomiting, stomach pain, headaches, diarrhea, and mild skin rashes.

Mesalamine may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Mesalamine should be stored at room temperature, away from moisture and heat, and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.